NCT07056881

Brief Summary

This study looks at how well one antibiotic (monotherapy) works compared to two antibiotics (combination therapy) in treating bone infections caused by Pseudomonas aeruginosa. It includes 300 adult patients who had this type of infection confirmed by lab tests and medical imaging. The goal is to find out if using just one antibiotic is as effective as using two, while also looking at side effects, the need for more surgery, antibiotic resistance, and overall antibiotic use.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 11, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 30, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 9, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2026

Completed
Last Updated

July 9, 2025

Status Verified

June 1, 2025

Enrollment Period

1 year

First QC Date

June 30, 2025

Last Update Submit

June 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical cure rate at the end of antibiotic treatment, defined as resolution of signs and symptoms of infection without need for additional antibiotic therapy or surgical intervention.

    6 weeks

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be selected from the electronic health records of adult patients hospitalized within the AP-HP (Assistance Publique-Hôpitaux de Paris) network. The study population includes individuals diagnosed with osteitis or osteomyelitis who have a confirmed microbiological diagnosis of Pseudomonas aeruginosa infection, along with imaging consistent with bone infection.

You may qualify if:

  • Adult patients (≥18 years old)
  • Diagnosis of osteitis or osteomyelitis due to Pseudomonas aeruginosa
  • Isolation of Pseudomonas aeruginosa from at least one deep, sterile sample (e.g., bone biopsy, joint aspiration)
  • Imaging findings consistent with osteomyelitis (MRI, CT scan, or X-ray)

You may not qualify if:

  • No isolation of Pseudomonas aeruginosa
  • No imaging evidence suggestive of osteomyelitis
  • Patients under 18 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier de Saint-Denis

Saint-Denis, France, France

RECRUITING

MeSH Terms

Conditions

OsteomyelitisPseudomonas InfectionsBacterial Infections

Condition Hierarchy (Ancestors)

Bone Diseases, InfectiousInfectionsBone DiseasesMusculoskeletal DiseasesGram-Negative Bacterial InfectionsBacterial Infections and Mycoses

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 30, 2025

First Posted

July 9, 2025

Study Start

April 11, 2025

Primary Completion

April 15, 2026

Study Completion

April 15, 2026

Last Updated

July 9, 2025

Record last verified: 2025-06

Locations